Stay updated on MCS110 in Prostate Cancer With Bone Metastases Clinical Trial

Sign up to get notified when there's something new on the MCS110 in Prostate Cancer With Bone Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MCS110 in Prostate Cancer With Bone Metastases Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:24:24.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of a Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases, evaluating the safety and efficacy of MCS110 in patients with prostate cancer and bone metastases.
    Difference
    0.2%
    Check dated 2024-06-06T14:31:24.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for patients with asymptomatic castrate-resistant prostate cancer with bone metastases, specifying that they must not have received bisphosphonates in the 12 months prior to enrollment. Previously, this section had no information provided.
    Difference
    15%
    Check dated 2024-05-22T21:25:09.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:28:42.000Z thumbnail image

Stay in the know with updates to MCS110 in Prostate Cancer With Bone Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MCS110 in Prostate Cancer With Bone Metastases Clinical Trial page.